Listed

NeuroPace Inc

NPCENasdaqCIK 1528287HealthcareFiscal year ends Dec 31

Reports and events: 81 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

NeuroPace Inc, Reports and events
FiledFormWhat it isAccession number
2026-08-1116:33 ET10-QQuarterly reportPeriod 2026-06-300001528287-26-000030
2026-08-1116:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-26-000027
2026-07-2816:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-321083
2026-06-0816:54 ET8-K5.07 Shareholder vote results0001193125-26-261965
2026-05-1216:45 ET10-QQuarterly reportPeriod 2026-03-310001528287-26-000022
2026-05-1216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-26-000019
2026-04-2116:05 ETDEF 14AProxy statementPeriod 2026-06-050001140361-26-015894
2026-03-0316:54 ET10-KAnnual reportPeriod 2025-12-310001528287-26-000011
2026-03-0316:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-26-000008
2025-11-0416:22 ET10-QQuarterly reportPeriod 2025-09-300001528287-25-000032
2025-11-0416:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-25-000030
2025-08-1217:16 ET10-QQuarterly reportPeriod 2025-06-300001528287-25-000022
2025-08-1216:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-25-000021
2025-06-2416:14 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-145738
2025-06-1216:16 ET8-K5.07 Shareholder vote results0001193125-25-139896
2025-06-0416:35 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-134946
2025-05-2708:09 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-126268
2025-05-1317:15 ET10-QQuarterly reportPeriod 2025-03-310001528287-25-000013
2025-05-1316:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-25-000012
2025-04-2216:00 ETDEF 14AProxy statementPeriod 2025-06-060001140361-25-014896
2025-04-1416:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-080217
2025-04-0216:38 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-071399
2025-03-0417:05 ET10-KAnnual reportPeriod 2024-12-310001528287-25-000007
2025-03-0416:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-25-000006
2025-02-2016:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-030729
2025-02-1808:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-028174
2025-02-1406:11 ET8-K1.01 Entry into a material agreement0001193125-25-026573
2025-01-2817:25 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-014473
2025-01-1516:43 ET8-K7.01 Regulation FD disclosure0001193125-25-007085
2025-01-0816:38 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-003547
2024-11-1217:15 ET10-QQuarterly reportPeriod 2024-09-300001528287-24-000020
2024-11-1216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-24-000019
2024-08-1317:14 ET10-QQuarterly reportPeriod 2024-06-300001528287-24-000016
2024-08-1316:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-24-000015
2024-06-1017:30 ET8-K5.07 Shareholder vote results0001193125-24-158459
2024-05-0817:17 ET10-QQuarterly reportPeriod 2024-03-310001528287-24-000011
2024-05-0816:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-24-000010
2024-04-2217:00 ETDEF 14AProxy statementPeriod 2024-06-070001140361-24-021062
2024-03-0517:00 ET10-KAnnual reportPeriod 2023-12-310001528287-24-000005
2024-03-0516:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-24-000004
2024-02-0716:43 ET8-K5.02 Departure or appointment of officers or directors0001193125-24-026756
2024-01-0807:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-003861
2023-12-0417:01 ET8-K1.01 Entry into a material agreement0001193125-23-288474
2023-11-0616:55 ET10-QQuarterly reportPeriod 2023-09-300001528287-23-000041
2023-11-0616:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-23-000040
2023-08-0816:56 ET10-QQuarterly reportPeriod 2023-06-300001528287-23-000034
2023-08-0816:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001528287-23-000033
2023-07-1916:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-189608
2023-06-2816:06 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-177492
2023-06-1216:14 ET8-K5.07 Shareholder vote results0001528287-23-000028

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.